Who
Andreas Grauer
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Sagimet Biosciences; Chief Medical Officer, Corcept Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Apr 2019
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 20 Apr 2026filed 14 May 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —264,759 at $0.00 | filing |
| 20 Apr 2026filed 14 May 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —264,759 at $0.00 | filing |
| 5 Feb 2021filed 8 Feb 2021 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 7 Feb 2020filed 11 Feb 2020 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 1 Apr 2019filed 2 Apr 2019 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —425,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.